Response to: Investigating the neurobehavioral symptoms of neuronopathic Hunter syndrome.

Eisengart, J B; King, K E; Shapiro, E; Whitley, C B; Muenzer, J

Eisengart, J B; King, K E; Shapiro, E; Whitley, C B; Muenzer, J.

Afiliación

Eisengart JB; Division of Clinical Behavioral Neuroscience, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.
King KE; Division of Clinical Behavioral Neuroscience, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.
Shapiro E; Division of Clinical Behavioral Neuroscience, Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.
Whitley CB; Shapiro Neuropsychology Consulting, LLC, Portland, OR, USA.
Muenzer J; Department of Experimental and Clinical Pharmacology and Department of Pediatrics, University of Minnesota, Minneapolis, MN, USA.

Mol Genet Metab Rep ; 22: 100570, 2020 Mar.

Article en En | MEDLINE | ID: mdl-32055445

Palabras clave

Behavioral decline; Hunter syndrome; Mucopolysaccharidosis II; Neurobehavioral symptoms; Neuronopathic phenotype

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Mol Genet Metab Rep Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google